# Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding

> **NCT01190150** · PHASE4 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 20 (actual)

## Conditions studied

- Menorrhagia

## Interventions

- **DRUG:** tranexamic acid

## Key facts

- **NCT ID:** NCT01190150
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01190150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01190150, "Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01190150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*